InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Inks Acquisition Deal to Expand in the US

AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China, and its subsidiary Foodbase Group Inc, have signed a definitive equity purchase agreement; the agreement outlines the acquisition of a group of affiliated companies: SLV Windfall Group LLC, Windfall SLV Development LLC and SLV Windfall Management LLC. These companies are engaged in developing, marketing and selling real estate in a planned community in McCormick County, South Carolina, called Savannah Lakes Village. According to the announcement, SLV Windfall Group LLC owns dozens of buildable lots along with some 500 acres of undeveloped land for future development projects and the exclusive right to purchase additional buildable lots. Savannah Lakes Village is a well-developed, three-decade-old community. “We believe this acquisition will expand the scope of our operations meaningfully and bring significant value to our shareholders,” said AnPac Bio-Medical Science co-CEO Haohan Xu in the press release. “We are in the process of acquiring some business-to-business e-commerce food businesses. The acquisition of the SLV project will potentially give the company an opportunity to use the 500 acres of undeveloped land to build low-costs, smart-food warehouse and distribution centers. We also plan to build and sell residential properties with great profit potential, thanks to the favorable terms granted by the local land authorities and use the profits generated from the sale of these residential properties to fund the construction of the smart food warehouse and distribution centers.”

To view the full press release, visit https://ibn.fm/7JzmZ

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company intends to enter the business-to-business e-commerce food business with the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.